shine-logo

SHINE Therapeutics

Home » SHINE Therapeutics

SHINE & IOCB deliver Lu-177 doses to GE

SHINE Medical Technologies LLC, the Institute of Organic Chemistry and Biochemistry (IOCB Prague) and GE Healthcare today announced the production of patient doses of the therapeutic isotope lutetium-177 (Lu-177).

2022-09-08T09:15:03-05:00January 21, 2020|Healthier, News, News Releases, Medical Isotopes, Therapeutics, 2020|

SHINE Creates Therapeutics Division

SHINE Medical Technologies today announced the creation of a new division of the company — SHINE Therapeutics. The establishment of the division enhances the company’s ability to focus on filling critical future needs in the rapidly growing therapeutic isotope market, while continuing to leverage its radioisotope production expertise.

2021-12-17T17:41:45-06:00October 11, 2019|News Releases, Archived, Medical Isotopes, 2019|
Go to Top